...
首页> 外文期刊>Clinical pharmacist >Idiopathic pulmonary fibrosis clinical features and diagnosis
【24h】

Idiopathic pulmonary fibrosis clinical features and diagnosis

机译:特发性肺纤维化的临床特点和诊断

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Idiopathic pulmonary fibrosis (IPF) is one of many conditions that are grouped together under the term "interstitial lung diseases". Despite considerable heterogeneity in the cause, presentation, treatment options and outcomes of these conditions, the interstitial lung diseases are grouped together because of similarities in clinical and radiological presentation (see Box 1, p221). The complex and historically inconsistent terminology, multitude and relative rarity of individual subtypes of interstitial lung disease contribute to confusion in their diagnosis and description. IPF, previously termed "cryptogenic fibrosing alveolitis" in the UK, is a chronic, progressive and fibrosing idiopathic interstitial pneumonia of unknown cause that occurs in older adults.' It is irreversible and has a poor prognosis - five-year survival is around 20% and median survival after diagnosis is around two and a half years.
机译:特发性肺纤维化(IPF)是在“间质性肺病”一词中归类在一起的许多疾病之一。尽管这些疾病的病因,表现,治疗选择和结果存在很大的异质性,但由于临床和放射学表现的相似性,间质性肺疾病仍被归类在一起(见方框1,p221)。间质性肺病各亚型的术语复杂,历史上不一致,种类繁多和相对稀少,导致其诊断和描述混乱。 IPF在英国以前称为“隐源性纤维化肺泡炎”,是一种原因不明的慢性,进行性和纤维化特发性间质性肺炎,发生于老年人。它是不可逆的且预后较差-五年生存率约为20%,诊断后的中位生存期约为两年半。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号